Lessons learned in the response to the 2003 SARS outbreak highlight the importance of testing SARS-CoV-2 vaccine candidates in animals and detecting neutralizing antibodies in people who have recovered from COVID-19, WHO Center for Reference and Research on Influenza Director Kanta Subbarao wrote in Cell Host and Microbe. Animal experiments with SARS-CoV-2 have shown that neutralizing antibodies protect from reinfection, Subbarao wrote.
Sign up for FBR SmartBrief
Biomedical Research News
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.